Schrödinger Inc., an American computational software developer for drug discovery, has raised a US$85 million financing round, led by The Bill and Melinda Gates Foundation Trust and Chinese biopharmaceutical company WuXi AppTec’s Corporate Venture Fund, according to an announcement released last Friday.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!
Register NowAlready have an account or paid subscription? Log in
